Beaumont Financial Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,222
| Closed | -$467K | – | 327 |
|
|
2023
Q2 | $467K | Buy |
2,222
+15
| +0.7% | +$3.15K | 0.04% | 199 |
|
|
2023
Q1 | $445K | Hold |
2,207
| – | – | 0.05% | 182 |
|
|
2022
Q4 | $481K | Sell |
2,207
-2
| -0.1% | -$436 | 0.05% | 177 |
|
|
2022
Q3 | $435K | Buy |
2,209
+93
| +4% | +$18.3K | 0.04% | 184 |
|
|
2022
Q2 | $453K | Buy |
2,116
+3
| +0.1% | +$642 | 0.04% | 187 |
|
|
2022
Q1 | $600K | Hold |
2,113
| – | – | 0.05% | 190 |
|
|
2021
Q4 | $796K | Hold |
2,113
| – | – | 0.06% | 163 |
|
|
2021
Q3 | $872K | Sell |
2,113
-15
| -0.7% | -$6.19K | 0.07% | 154 |
|
|
2021
Q2 | $787K | Buy |
+2,128
| New | +$787K | 0.06% | 164 |
|